Vimta Labs Ltd

NSE
VIMTALABS •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Vimta Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
67.88% Gain from 52W Low
14.7
TTM PE Ratio
Below industry Median
26.3
Price to Book Ratio
Below industry Median
3.9
Dividend yield 1yr %
Below industry Median
0.4
TTM PEG Ratio
PEG TTM is negative
-2.1
RSI
RSI is mid-range
59.8
MFI
MFI is mid-range
68.3

Vimta Labs Ltd Key Financials

*All values are in ₹ Cr.

Vimta Labs Ltd shareholding Pattern

Promoter
37%
Foreign Institutions
2.9%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.6%

Vimta Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
1
5Day EMA
486.90
10Day EMA
486.60
12Day EMA
485.30
20Day EMA
478.30
26Day EMA
473.00
50Day EMA
461.60
100Day EMA
459.30
200Day EMA
450.80
Delivery & Volume
Resistance & Support
489.58
Pivot
Resistance
First Resistance
496.17
Second Resistance
502.38
Third Resistance
508.97
Support
First Support
483.37
Second support
476.78
Third Support
470.57
Relative Strength Index
59.75
Money Flow Index
68.27
MACD
12.30
MACD Signal
14.47
Average True Range
19.51
Average Directional Index
34.06
Rate of Change (21)
12.66
Rate of Change (125)
-14.47

Vimta Labs Ltd Company background

Founded in: 1990
Managing director: Harita Vasireddi
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc. The Company was awarded ISO 9002 Certification under ISO/IEC Guide25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company begun to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.The Company is now expanding its operations by five times of its existing capacities at S P Biotech Park, Genome Valley, Turkapally Village, Shamirpet Mandal, Ranga Reddy Dist. The project is expected to commence from September 2005.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.
Read More

Vimta Labs Ltd FAQs

Vimta Labs Ltd shares are currently priced at 489.95 on NSE and 490.9 on BSE as of 2/21/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Vimta Labs Ltd [VIMTALABS] share was 55.07. The Vimta Labs Ltd [VIMTALABS] share hit a 1-year low of Rs. 291.85 and a 1-year high of Rs. 623.15.

The market cap of Vimta Labs Ltd is Rs. 1085.99 Cr. as of 2/21/2024 12:00:00 AM.

The PE ratios of Vimta Labs Ltd is 27.72 as of 2/21/2024 12:00:00 AM.

The PB ratios of Vimta Labs Ltd is 3.69 as of 2/21/2024 12:00:00 AM

The Mutual Fund Shareholding was 1.49% at the end of 2/21/2024 12:00:00 AM.

You can easily buy Vimta Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage